Suchergebnisse - "Maas, R"

PubPharm (451)

1

Correction to : IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells

enthalten in: Cancer immunology, immunotherapy : CII | 2021

von Van der Meer, J. | Maas, R. | Guldevall, K. | +15

ErratumFor: Cancer Immunol Immunother. 2021 May;70(5):1305-1321. - PMID 33140189

2

Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells

enthalten in: Cancer immunology immunotherapy | 2021

von Van der Meer, J. | Maas, R. | Guldevall, K. | +15

3

Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells

enthalten in: Cancer immunology immunotherapy | 2021

von Van der Meer, J. | Maas, R. | Guldevall, K. | +15

4

Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells

enthalten in: Cancer immunology immunotherapy | 2021

von Van der Meer, J. | Maas, R. | Guldevall, K. | +15

5

Die induzierbare laryngeale Obstruktion (ILO) – Ursachen, klinische Präsentation, Diagnostik und Therapie

enthalten in: Monatsschrift Kinderheilkunde | 2021

von Dillenhöfer, S. | Hinrichs, B. | Kohl, A. | +11

6

Die induzierbare laryngeale Obstruktion (ILO) – Ursachen, klinische Präsentation, Diagnostik und Therapie

enthalten in: Monatsschrift Kinderheilkunde | 2021

von Dillenhöfer, S. | Hinrichs, B. | Kohl, A. | +11

7

Die induzierbare laryngeale Obstruktion (ILO) – Ursachen, klinische Präsentation, Diagnostik und Therapie

enthalten in: Monatsschrift Kinderheilkunde | 2021

von Dillenhöfer, S. | Hinrichs, B. | Kohl, A. | +11

8

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

enthalten in: Cancer immunology, immunotherapy : CII | 2021

von Van der Meer, J. | Maas, R. | Guldevall, K. | +15

ErratumIn: Cancer Immunol Immunother. 2021 Nov;70(11):3367. - PMID 34524494

9

Therapeutic Exposure and Successful Response to Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer Despite Significant Renal Loss Due to Paraneoplastic Nephrotic Syndrome

enthalten in: Clinical lung cancer | 2021

von Jansen, A. | Sriram, J. | Pluim, D. | +4

10

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by $ CD34^{+} $ progenitor-derived NK cells

enthalten in: Cancer immunology immunotherapy | 2020

von Van der Meer, J. | Maas, R. | Guldevall, K. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[46]